Mangano A, Pittis G, Galindez C, Bologna R, Sen L
Laboratorio de Biología Celular y Retrovirus, Hospital de Pediatría "Juan P. Garrahan," Buenos Aires, Argentina.
AIDS Patient Care STDS. 1998 Sep;12(9):691-6. doi: 10.1089/apc.1998.12.691.
Early and accurate diagnosis of HIV-1 infection in infants born to HIV-1-seropositive mothers is of great importance. Polymerase chain reaction (PCR), HIV culture, and p24 antigen detection assays were evaluated for their ability to detect the presence of HIV in 195 infants at risk of perinatal infection. Using the Centers for Disease Control and Prevention guidelines for assessing HIV infection status in children younger than 18 months, 70 infants (36%) were diagnosed as HIV-1 infected and 125 (64%) lacked virologic and clinical evidence of infection. PCR and HIV culture were the most sensitive laboratory markers, detecting 100% and 98% of positive samples, respectively, regardless of age at testing. HIV-1 p24 antigen assay was detected in 26 of 38 positive samples but not in negative samples. PCR was performed with three different sets of primers (SK38/SK39-SK19-gag, SK68/SK69-SK70-env, and SK150/SK431-SK102-gag). The sensitivity/specificity of the individual assays were for SK19, 96.1%/94.25%; SK70, 89.6%/100%; and SK102, 100%/100%. A sample was considered HIV-1 positive when two positive PCR results were obtained with two different pairs of primers, and negative if the sample was negative when three sets of primers were used. False-positive results were occasionally obtained with probe SK19 in six seroreverter infants before serologic status was known. This suggested that the infection was caused by nonreplicative strains or were false-positive results probably by nonspecific amplification due to cross-reaction with other microorganisms; contamination was discarded because there was no specific amplification with the other two primers. All the HIV-1-infected infants were correctly identified with PCR; all except one could be identified with coculture and only 68.4% were confirmed with p24 antigen assay. No seroreverter infant was misdiagnosed using the criteria selected.
对人类免疫缺陷病毒1型(HIV-1)血清反应阳性母亲所生婴儿进行早期准确诊断极为重要。对聚合酶链反应(PCR)、HIV培养及p24抗原检测试验检测195名有围产期感染风险婴儿体内HIV存在的能力进行了评估。根据美国疾病控制与预防中心评估18个月以下儿童HIV感染状况的指南,70名婴儿(36%)被诊断为HIV-1感染,125名(64%)缺乏病毒学及感染的临床证据。PCR及HIV培养是最敏感的实验室指标,无论检测时的年龄如何,分别能检测出100%和98%的阳性样本。在38份阳性样本中的26份检测到HIV-1 p24抗原试验,但阴性样本中未检测到。PCR使用三组不同的引物(SK38/SK39-SK19-gag、SK68/SK69-SK70-env及SK150/SK431-SK102-gag)进行。各试验的敏感性/特异性分别为:SK19,96.1%/94.25%;SK70,89.6%/100%;SK102,100%/100%。当用两对不同引物获得两个阳性PCR结果时,样本被视为HIV-1阳性;当使用三组引物样本均为阴性时,则为阴性。在血清学状态未知前,6名血清转化婴儿偶尔用探针SK19获得假阳性结果。这表明感染是由非复制株引起,或者可能是由于与其他微生物交叉反应导致非特异性扩增产生的假阳性结果;由于另外两组引物未出现特异性扩增,排除了污染。所有HIV-1感染婴儿均通过PCR正确识别;除1例之外,所有婴儿均可通过共培养识别,仅68.4%通过p24抗原试验确诊。使用选定的标准,未误诊血清转化婴儿。